Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Cancers|June 23, 2019
Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for TemozolomideAnna-Laura Potthoff, Dieter Henrik Heiland, Bernd O Evert, et al.
Immunity, Inflammation and Disease|June 25, 2020
Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B studyMohummad A Rahman, Jorunn Brekke, Victoria Arnesen, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Inhibition of Intercellular Cytosolic Traffic via Gap Junctions Reinforces Lomustine-Induced Toxicity in Glioblastoma Independent of MGMT Promoter Methylation StatusMatthias Schneider, Anna-Laura Potthoff, Bernd O Evert, et al.
The Journal of Pathology|October 4, 2023
TRIM28 inactivation in epithelial nephroblastoma is frequent and often associated with predisposing TRIM28 germline variantsJenny Wegert, Anne Kristin Fischer, Balazs Palhazi, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 15, 2016
Is the molecular clock ticking differently in bipolar disorder? Methylation analysis of the clock gene ARNTLSusanne A Bengesser, Eva Z Reininghaus, Nina Lackner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2013
Anticancer effects of niclosamide in human glioblastomaAnja Wieland, Daniel Trageser, Sabine Gogolok, et al.
Molecular Oncology|December 16, 2024
Tonabersat enhances temozolomide-mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibitionElena N C Schmidt, Bernd O Evert, Barbara E F Pregler, et al.
Journal of Neuro-Oncology|January 9, 2016
Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous systemJohannes van de Nes, Marco Gessi, Antje Sucker, et al.
Plos One|September 23, 2025
Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical noteAnna-Laura Potthoff, Meng-Chun Hsieh, Ahmad Melhem, et al.
Neuro-Oncology|October 11, 2017
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor locationMichael Karremann, Gerrit H Gielen, Marion Hoffmann, et al.
Pageof 8